Rockefeller Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.7K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $262K | Buy |
|
|||||
|
2023
Q1 | $200K | Sell |
|
|||||
|
2022
Q4 | $273K | Sell |
|
|||||
|
2022
Q3 | $362K | Buy |
|
|||||
|
2022
Q2 | $330K | Sell |
|
|||||
|
2022
Q1 | $631K | Buy |
|
|||||
|
2021
Q4 | $733K | Buy |
|
|||||
|
2021
Q3 | $745K | Buy |
|
|||||
|
2021
Q2 | $564K | Buy |
|
|||||
|
2021
Q1 | $249K | Buy |
|
|||||
|
2020
Q4 | $209K | Hold |
|
|||||
|
2020
Q3 | $89K | Buy |
|